Balancing Patient Convenience with Environmental Protection

Kiran Mazumdar –Shaw, CMD Biocon There are nearly half a billion diabetes patients in the world today and by 2040 that number is expected to climb to over 640 million. Even as diabetes incidence grows across the globe, developed markets like the U.S. are grappling with astronomical prices of one of the key medications for … Continue reading Balancing Patient Convenience with Environmental Protection

My address to Biocon Women Employees on International Women’s Day 2019

Today, as the first women employee of Biocon, I celebrate a lot of things done right at Biocon in last 40 years. When I started Biocon in 1978, there were very few women keen in business space.  I was perhaps the first tech startup in India because IT came to India a little later after … Continue reading My address to Biocon Women Employees on International Women’s Day 2019

IHC Public Lecture: Strategic Importance Of Data Sciences In Research And Innovation

DATA IS KING In 2012, IDC projected that the digital universe will reach 40 zettabytes by 2020. This was based on the assumption that 1.7 megabytes of new information will be created every second for every human being on the planet in 2020. IDC realised that its projection was on the conservative side! Its current … Continue reading IHC Public Lecture: Strategic Importance Of Data Sciences In Research And Innovation

A Journey of Endurance

By Kiran Mazumdar Shaw, CMD, Biocon The approval of our biosimilar Trastuzumab by the U.S. FDA is a vindication of our two-decade-long biologics-led pharmaceutical journey. We had invested ‘ahead of the curve’ in the promising future of targeted biologics at the turn of the millennium. At that time, we had anticipated some of the risks, … Continue reading A Journey of Endurance

India To Be A Biotech Hot Spot

The last 70 years have been transformational for the Indian biotech industry, mirroring the nation’s own rapidly advancing economy and rising global status. We have successfully leveraged recombinant DNA technology to deliver biopharmaceuticals, vaccines, genetically engineered crops and enzymes. In doing so, we have created a notable bio-economy valued at $35 billion. We have embraced … Continue reading India To Be A Biotech Hot Spot

eHealth Push Can Build a ‘Swastha Bharat’ in 2017

2016 was a landmark year for India as demonetisation nudged the country towards an inclusive, less-cash dependant, digital future. In 2017, the government should push for the increased adoption of technology to transform the country’s public healthcare system and ensure a healthy future for all Indians. The low priority accorded to healthcare in India over … Continue reading eHealth Push Can Build a ‘Swastha Bharat’ in 2017

Innovation, not price control is the answer to affordable Bt cotton technology

The biggest threat to cotton farmers is the bollworm, because of its ability to cause extraordinary damage to crops and livelihoods. In the 1990s, pesticides were the only weapon farmers had against the bollworm. Half of all the pesticide consumption in India was accounted for by just one crop – cotton. Yet, the ability of … Continue reading Innovation, not price control is the answer to affordable Bt cotton technology

Why FY14 was a Remarkable Year for Biocon

The fiscal year gone by has been one of the most exciting ones for Biocon. We delivered on our promise of affordable innovation, recorded robust top line and bottom line growth, augmented our capacities, optimized our product portfolio and introduced initiatives to achieve operational efficiencies. We successfully commercialized two world-class, low-cost monoclonal antibodies, an outcome … Continue reading Why FY14 was a Remarkable Year for Biocon